$ABVC SEC Filings

Filed On	Filing
29 Sep 2026	Proxy statement: special meeting on October 28, 2026
11 Sep 2026	REVISED PRELIMINARY PROXY STATEMENT
27 Aug 2026	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
25 Aug 2026	REVISED PRELIMINARY PROXY STATEMENT
17 Aug 2026	PROSPECTUS SUPPLEMENT
17 Aug 2026	PROSPECTUS SUPPLEMENT
17 Aug 2026	PROSPECTUS SUPPLEMENT
17 Aug 2026	PROSPECTUS SUPPLEMENT
12 Aug 2026	REVISED PRELIMINARY PROXY STATEMENT
12 Aug 2026	QUARTERLY REPORT
12 Aug 2026	8-K/A: Other Events On August 3, 2026, ABVC BioPharma, Inc. (the “Company”) determined to postpone the previously announced distribution of ordinary shares of BioKey (Cayman), Inc. (the “Distribution”), which had been scheduled to occur on August 3, 2026. T...
04 Aug 2026	8-K: Other Events
28 Jul 2026	PRELIMINARY PROXY STATEMENT
02 Jul 2026	8-K: Changes in Registrant's Certifying Accountant
18 May 2026	QUARTERLY REPORT
15 May 2026	NOTIFICATION OF LATE FILING
27 Mar 2026	POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1
27 Mar 2026	8-K: Submission of Matters to a Vote of Security Holders
05 Mar 2026	Proxy statement: annual meeting on March 26, 2026
03 Mar 2026	AMENDMENT NO. 1 TO FORM 10-Q

Comments